Episode 188: Nathan Buchbinder – A Deep Dive Into Proscia’s Precision Medicine AI Portfolio
Nathan Buchbinder from Proscia returns to discuss Proscia’s Precision Medicine AI Portfolio.
-
The portfolio includes leading AI applications available on the Concentriq platform.
-
The portfolio streamlines the process of deploying, supporting, and using AI applications in pathology.
-
The portfolio includes applications from Proscia and other developers, including Ibex, Visiopharm, Stratipath, DoMore Diagnostics, Mindpeak, Nucleai.
-
Collaboration with other vendors and developers is important to address the variety of AI applications needed and helps streamline the process.
-
Multi-AI workflows on Concentriq enable the simultaneous use of multiple AI applications on a single image or work list.
-
The Precision Medicine AI portfolio supports analysis of various tissue types, with a growing portfolio.
-
The partnership with Nucleai enhances the functionality of Concentriq by incorporating AI biomarkers.
-
Proscia’s is focused on expanding the Precision Medicine AI portfolio, making platform enhancements, and adding new functionality.
Proscia is not the legal manufacturer of the products available in its precision medicine AI portfolio and pipeline. Certain products may only be available for diagnostic use in select geographies. Please contact Proscia for availability of an application in your geography.
Multi-AI workflows are available on Concentriq AP. Concentriq AP is for research use only. Not for use in diagnostic procedures.
Links for this episode:
Labvine Laboratory Transformation Seasonal School
Concentriq AP: A New Era of AI in Pathology Webinar
People of Pathology Podcast:
